September 2023

iSpecimen Unveils Organizational Changes to Boost Efficiency and Drive Profitability

newsmaker03 mins

iSpecimen Announces Organizational Changes to Enhance Operational Efficiency Company to Focus on Core Revenue Drivers New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense Reductions LEXINGTON, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical…

Read More

Revolutionizing Aerospace Sustainability: IperionX and Heroux Devtek Join Forces for Titanium Recycling

newsmaker04 mins

IperionX and Heroux-Devtek Sign Groundbreaking Agreement Revolutionizing the Aerospace Industry with 100% Recycled Titanium CHARLOTTE, N.C.–IperionX Limited (“IperionX”) and Heroux-Devtek have recently announced a partnership that is set to transform the aerospace industry. This collaboration aims to establish a sustainable supply chain for titanium by utilizing scrap titanium metal from the aerospace sector. Heroux-Devtek, renowned…

Read More

Insights on Bobi Wine’s Tour: A Personal Observation by George Mubiru

marketnews04 mins

GEORGE MUBIRU: My observation about Bobi Wine’s tour Introduction I have keenly observed Kyagulanyi’s rallies in western Uganda and physically attended those in Mayuge and Busia as a researcher and analyst. So far I have made the following observations. Observations Police and other security forces have exhibited high professionalism and ensured that these rallies are…

Read More

Breaking News: United Therapeutics Corporation Takes Legal Action Against Alleged Infringement of Tyvaso Patent, Despite Previous Invalidity Ruling by U.S. Patent Office

marketinsider03 mins

United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Overview United Therapeutics Corporation recently filed a lawsuit under the Hatch-Waxman Act, asserting their ‘793 patent in response to Liquidia’s amendment to its New Drug Application (NDA) to include PH-ILD on the label of YUTREPIA™. This new litigation comes after the ‘793 patent was previously…

Read More

Unlocking the Future: Olema Oncology’s Exciting Presence at Upcoming Investor Conferences

marketinsider04 mins

Unlocking the Future: Olema Oncology’s Exciting Presence at Upcoming Investor Conferences Description: SAN FRANCISCO, Sept. 06, 2023 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company will present at the following…

Read More

Gecko Minerals Gets a Jolt: Javelin Minerals Takes Over to Boost Uganda’s Lithium Prospects!

marketinsights04 mins

Javelin Minerals to supercharge Uganda’s lithium prospects through strategic takeover bid with Gecko Minerals A game-changing partnership In a move set to revolutionize Uganda’s lithium exploration and production efforts, Javelin Minerals recently inked a strategic takeover bid implementation agreement with Gecko Minerals. This strategic maneuver has garnered unanimous support from Gecko’s directors, who wholeheartedly recommend…

Read More